Reuters logo
BRIEF-Tianjin Chase Sun Pharma sees H1 net profit rising up to 20 pct
July 14, 2015 / 8:54 AM / 2 years ago

BRIEF-Tianjin Chase Sun Pharma sees H1 net profit rising up to 20 pct

July 14 (Reuters) - Tianjin Chase Sun Pharmaceutical Co Ltd

* Says expects H1 net profit to rise up to 20 percent y/y to 220.5-264.6 million yuan ($35.511-$42.62 million)

Source text in Chinese: bit.ly/1HsGbVa

Further company coverage: ($1 = 6.2088 Chinese yuan renminbi) (Reporting by Hong Kong and Singapore newsrooms)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below